Risks of Stroke in Glycogen Storage Disease Type I

Abstract

Abstract:

Glycogen storage disease type I is an autosomal recessive inborn error of carbohydrate metabolism caused by defects of the glucose-6-phosphatase (G6Pase) complex, which results in accumulation of glycogen in liver, kidney and intestine. Patients have marked hyperlipidaemia in early stage, moreover, there would develop long-term complications such as renal insufficiency, hypertension, all adding to risk factors for atherosclerosis, thus increase the risk for stroke. Herein, we reviewed the 6 cases reports that presented GSD1 patients with stroke. While the underlying mechanisms remained elusive, some authors advocated that GSD1 were predisposed to premature atherosclerosis and stroke, on the contrary, some authors suggested an antiatherosclerosis mechanism, studies regarding the above two distinct perspectives were reviewed.

Key words: Glycogen storage disease type I; Hyperlipidaemia; Atherosclerosis; Stroke

摘要：

糖原贮积病（glycogen storage disease，GSD）为糖原代谢障碍导致糖原在肝脏、肌肉、肾脏等组织器官中贮积所致的一组遗传代谢性疾病，根据酶缺陷不同，至少可分为12型，以GSD1型最常见，GSD1早期可继发显著的高脂血症，随年龄增长可能出现肾功能不全、高血压等远期并发症，这些均为动脉粥样硬化的危险因素，可能增加卒中风险。本文依据GSD1合并卒中的病例报告，探讨GSD1卒中发生的相关机制，目前主要有两种观点：其一认为GSD1患者是早期动脉粥样硬化、卒中的高危人群；其二认为GSD1有显著高脂血症而卒中发病率小，可能具有抗动脉粥样硬化机制，本文从以上两方面分别阐述。

关键词: 糖原贮积病1型; 高脂血症; 动脉粥样硬化; 卒中

HONG Yue-Hui, PENG Bin, QIU. Risks of Stroke in Glycogen Storage Disease Type I[J]. Chinese Journal of Stroke, 2015, 10(10): 896-901.

洪月慧，彭斌，邱正庆. 糖原贮积病1型患者卒中风险的研究现状[J]. 中国卒中杂志, 2015, 10(10): 896-901.

References

1 Mayatepek E, Hoffmann B, Meissner T. Inborn errors

of carbohydrate metabolism[J]. Best Pract Res Clin

Gastroenterol, 2010, 24:607-618.

2 Rake JP, Visser G, Labrune P, et al. Glycogen storage

disease type I:diagnosis, management, clinical course

and outcome. Results of the European Study on

Glycogen Storage Disease Type I (ESGSD I)[J]. Eur J

Pediatr, 2002, 161(Suppl 1):S20-34.

3 Smit GP. The long-term outcome of patients with

glycogen storage disease type Ia[J]. Eur J Pediatr,

1993, 152(Suppl 1):S52-55.

4 郭立琳, 徐瑞燚, 朱文玲. 糖原累积症Ⅰ型心血管受累

的临床分析[J]. 中华心血管病杂志, 2011, 39:508-514.

5 Meschia JF, Bushnell C, Boden-Albala B, et al.

Guidelines for the Primary Prevention of Stroke:A

Statement for Healthcare Professionals From the

Amer ican Hear t Association /Amer ican St roke

Association[J]. Stroke, 2014, 45:3754-3832.

6 Fine RN, Podosin R, Donnell GN. Acute hemiplegia

in glycogen storage disease type 1[J]. Acta Paediatr

Scand, 1969, 58:621-624.

7 Aydinli N, Tatli B, Caliskan M, et al. Stroke in

childhood:experience in Istanbul, Turkey[J]. J Trop

Pediatr, 2006, 52:158-162.

8 Goulart JM, Yoo JY, Kirchoff-Torres KF, et al.

Ischemic stroke in an adult with glycogen storage

disease type I[J]. J Clin Neurosci, 2010, 17:1467-1469.

9 Berzsenyi MD, Brady BM, O’Donnell CJ, et al.

Cerebrovascular disease in type 1A glycogen storage

disease[J]. J Clin Neurosci, 1998, 5:93-94.

10 Sunder TR. Moyamoya disease in a patient with type I

glycogenosis[J]. Arch Neurol, 1981, 38:251-253.

11 Egashira Y, Takahashi JC, Ohnishi H, et al. Surgical

t reatment and per ioperat ive management of

moyamoya disease associated with glycogen storage

disease Type 1a[J]. J Neurosur-gery, Pediatrics, 2011,

7:11-14.

12 Goutières F, Bourgeois M, Trioche P, et al. Moyamoya

disease in a child with glycogen storage disease type

Ia[J]. Neuropediatrics, 1997, 28:133-134.

13 Weiss C, Witt TN, Fesl G, et al. Angiographic

moyamoya in a female with glycogenosis type IA-a

case report focusing therapeutic management:bilateralencephalo-duro-arterio-myo-synangiosis(EDAMS)[J].

Fortschr Neurol Psychiatr, 2010, 78:154-160.

14 Austin SL, EI-Gharbawy AH, Kasturi VG, et al.

Menorrhagia in patients with type I glycogen storage

disease[J]. Obstet Gynecol, 2013, 122:1246-1254.

15 Pi z zo CJ. Ty pe I g lycogen storage d i sease

with focal nodular hyperplasia of the liver and

vasoconst r ict ive pulmonary hyper tension[J ].

Pediatrics, 1980, 65:341-343.

16 Talente GM, Coleman RA, Alter C, et al. Glycogen

storage disease in adults[J]. Ann Intern Med, 1994,

120:218-226.

17 Smit GP, Fernandes J, Leonard JV, et al. The longterm

outcome of patients with glycogen storage

diseases[J]. J Inherit Metab Dis, 1990, 13:411-418.

18 Kishnani PS, Austin SL, Arn P, et al. Glycogen

storage disease type III diagnosis and management

guidelines[J]. Genet Med, 2010, 12:446-463.

19 Carvalho PM, Silva NJ, Dias PG, et al. Glycogen

Storage Disease type 1a - a secondary cause for

hyperlipidemia:report of five cases[J]. J Diabetes

Metab Disord, 2013, 12:25.

20 Fernández -Friera L, Ibanez B and Fuster V. Imaging

subclinical atherosclerosis:is it ready for prime time?

A review[J]. J Cardiovasc Transl Res, 2014, 7:623-634.

21 Yekeler E, Dursun M, Emeksiz E, et al. Prediction of

premature atherosclerosis by endothelial dysfunction

and increased intima-media thickness in glycogen

storage disease types Ia and Ⅲ[J]. Turk J Pediatr,

2007, 49:115-119.

22 Bernier AV, Correia CE, Haller MJ, et al. Vascular

Dysfunction in Glycogen Storage Disease Type I[J]. J

Pediatr, 2009, 154:588-591.

23 Lee PJ, Celermajer DS, Robinson J, et al. Hyperlipidaemia

does not impair vascular endothelial function in

glycogen storage disease type 1a[J]. Atherosclerosis,

1994, 110:95-100.

24 Ubels FL, Rake JP, Slaets JP, et al. Is glycogen storage

disease 1a associated with atherosclerosis?[J]. Eur J

Pediatr, 2002, 161(Suppl 1):S62-64.

25 Fathi R, Marwick TH. Noninvasive tests of vascular

function and structure:why and how to perform

them[J]. Am Heart J, 2001, 141:694-703.26 Wittenstein B, Klein M, Finckh B, et al. Radical

trapping in glycogen storage disease 1a[J]. Eur J

Pediatr, 2002, 161(Suppl 1):S70-74.

27 Koren E, Lipkin J, Klar A, et al. Total oxidantscavenging

capacities of plasma from glycogen

storage disease type Ia patients as measured by cyclic

voltammetry, FRAP and luminescence techniques[J].

J Inherit Metab Dis, 2009, 32:651-659.

28 Kalkan US, Coker M, Sozmen E, et al. A monocentric

pilot study of an antioxidative defense and hsCRP

in pediatric patients with glycogen storage disease

type IA and Ⅲ[J]. Nutr Metab Cardiovasc Dis, 2009,

19:383-390.

29 Muhlhausen C, Schneppenheim R, Budde U, et al.

Decreased plasma concentration of von Willebrand

factor antigen (VWF:Ag) in patients with glycogen

storage disease type Ia[J]. J Inherit Metab Dis, 2005,

28:945-950.

30 Marfaing-Koka A, Wolf M, Boyer NC, et al. Increased

levels of hemostatic proteins are independent of

inflammation in glycogen storage disease type Ia[J]. J

Pediatr Gastroenterol Nutr, 2003, 37:566-570.

31 Rosenson RS, Brewer HB Jr, Davidson WS, et al.

Cholesterol efflux and atheroprotection:advancing

the concept of reverse cholesterol transport[J].

Circulation, 2012, 125:1905-1919.

32 Prosser HC, Ng MK, Bursill CA. The role of cholesterol

efflux in mechanisms of endothelial protection by

HDL[J]. Curr Opin Lipidol, 2012, 23:182-189.

33 Andrew DN, Chi-Jiunn P, Jeng-Jer S, et al. Increased

cellular cholesterol efflux in glycogen storage disease

type Ia:A potential mechanism that protects against

premature atherosclerosis[J]. FEBS Lett, 2005,

579:4713-4718.

34 Nguyen AD, Pan CJ, Weinstein DA, et al. Increased

scavenger receptor class B type I-mediated cellular

cholesterol efflux and antioxidant capacity in the sera

of glycogen storage disease type Ia patients[J]. Mol

Genet Meta, 2006, 89:233-238.

35 Tamaki M, Tamura Y, Ogihara T, et al. Lack of evident

atherosclerosis despite multiple risk factors in glycogen

storage disease type 1a with hyperadiponectinemia[J].

Metabolism, 2007, 56:1402-1404.

[1]	CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.
[2]	FU Pengcheng, CAO Liming, ZHU Jiaqian, ZHAO Guiyu, XU Gelin. Research Progress of Reperfusion Therapy for Large Artery Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1004-1011.
[3]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[4]	JIANG He, WANG Cheng, CHEN Xianghua, XU Chunxiang. Predictive Value of Five Prehospital Stroke Screening Scales for In-Hospital Acute Large Vessel Occlusive Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1018-1024.
[5]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[6]	WANG Shuo, YU Ping, ZHANG Ning, WANG Chunxue. Bibliometric Analysis of References on the Correlation between Ischemic Stroke and Sleep from 2013 to 2023 [J]. Chinese Journal of Stroke, 2024, 19(9): 1040-1047.
[7]	ZHOU Hongyu, LI Zixiao, WANG Yongjun. Research Progress on Radiomics-Based Brain Age Prediction and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1066-1076.
[8]	ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
[9]	YANG Jinbo, ZHANG Cong. Progress on the Application of High-Resolution Vessel Wall Imaging in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1086-1093.
[10]	WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101.
[11]	WANG Ye, WEI Chenming, LI Xiuli, WU Jian. Application of Diversified Teaching Model in Stroke Green Channel Training at a Medical University-Affiliated Teaching Hospital [J]. Chinese Journal of Stroke, 2024, 19(9): 1102-1109.
[12]	SHAN Kai, ZHAO Meng, WANG Chunjuan, LI Zixiao, WANG Xiaoyan. Exploration and Practice of Diagnosis and Treatment Models for Stroke and Comorbid Conditions [J]. Chinese Journal of Stroke, 2024, 19(8): 863-865.
[13]	ZHANG Mengruo, XU Shouchen, SUI Cuicui, LI Yukui, WANG Xueli. The Effects of Lower Limb Rehabilitation Robot Combined with Scalp Acupuncture on the Walking Efficiency and Coordination Function in Elderly Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(8): 902-908.
[14]	XUE Mingyue, ZHANG Huixin, SU Dan, LI Lixia, LI Jingwei, LI Hong. Analysis of the Influencing Factors of Medication Adherence in Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 909-914.
[15]	WU Yuqian, ZHANG Yumei, ZANG Dawei, FAN Xiaowei, WANG Anxin, ZHANG Xiaoli, MENG Xia. Study on the Reliability, Validity, and Sensitivity of Action Research Arm Test Scale in Evaluating the Function of Hemiplegic Upper Limb and Hand in Subacute Stage Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 915-923.